Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

IT:ARKG ETF Forecast & Price Targets

Compare
See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

IT:ARKG Analyst Ratings

Moderate Buy
34ConsensusRatings
32Buy2Hold0Sell
Based on the Wall Street analyst consensus for 34 of IT:ARKG’s holdings.

IT:ARKG 12 Month Forecast

$11.22▲(39.16% Upside)
Based on Wall Street analyst 12-month price targets for 34 of Ark Genomic Revolution Ucits ETF AccumUSD’s holdings in the last 3 months. The average price target is $11.22 with a high forecast of $15.92 and a low forecast of $7.28. The average price target represents a 39.16% change from the last price of $8.06.
Highest Price Target$15.92Average Price Target$11.22Lowest Price Target$7.28

IT:ARKG Stocks With Highest Upside Potential

IT:ARKG highest upside
NamePrice & ChangeAnalyst ConsensusAnalyst Price Target
Strong Buy$51.75(188.14% Upside)
Moderate Buy$2.95(156.52% Upside)
Strong Buy$53.73(118.76% Upside)
Strong Buy$24.91(114.18% Upside)
Strong Buy$7.67(105.54% Upside)

IT:ARKG Stocks With Highest Downside Potential

IT:ARKG highest downside
NamePrice & ChangeAnalyst ConsensusAnalyst Price Target
Moderate Buy$57.00(-17.58% Downside)
Moderate Buy$249.13(-7.53% Downside)
Moderate Buy$2.02(-1.94% Downside)
Strong Buy$410.08(2.17% Upside)
Hold$16.25(2.72% Upside)

IT:ARKG ETF FAQ

What is IT:ARKG’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 34 of IT:ARKG’s holdings, Ark Genomic Revolution Ucits ETF AccumUSD’s 12-month average price target is $11.22.
What is IT:ARKG’s upside potential, based on the analysts’ average price target?
IT:ARKG’s average price target of $11.22 represents a 39.16% upside from its last price of $8.06.
Is IT:ARKG a Buy, Sell or Hold?
Ark Genomic Revolution Ucits ETF AccumUSD has a consensus rating of Moderate Buy, based on the analyst consensus for 34 of IT:ARKG’s holdings: 32 rated Buy, 2 rated Hold and 0 rated Sell.
What is Ark Genomic Revolution Ucits ETF AccumUSD’s price target?
The average price target for Ark Genomic Revolution Ucits ETF AccumUSD is $11.22, based on Wall Street analyst 12-month price targets for 34 of IT:ARKG’s holdings, issued in the past 3 months. The highest price target is $15.92 and the lowest is $7.28. The average price target represents a 39.16% increase from the last price of $8.06.
What is IT:ARKG’s expense ratio?
IT:ARKG’s expense ratio is 0.79%.
How many holdings does IT:ARKG have?
IT:ARKG holds 35 assets.
How can I buy shares of IT:ARKG?
You can buy shares of IT:ARKG through a brokerage account. Compare brokers on our Best Online Brokers page.